Inhibiting Geranylgeranylation Increases Neurite Branching and Differentially Activates Cofilin in Cell Bodies and Growth Cones
Authors:
- 11 February 2014
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 50 (1) , 49-59
Abstract
Inhibitors of the mevalonate pathway, including the highly prescribed statins, reduce the production of cholesterol and isoprenoids such as geranylgeranyl pyrophosphates. The Rho family of small guanine triphosphatases (GTPases) requires isoprenylation, specifically geranylgeranylation, for activation. Because Rho GTPases are primary regulators of actin filament rearrangements required for process extension, neurite arborization, and synaptic plasticity, statins may affect cognition or recovery from nervous system injury. Here, we assessed how manipulating geranylgeranylation affects neurite initiation, elongation, and branching in neuroblastoma growth cones. Treatment with the statin, lovastatin (20 μM), decreased measures of neurite initiation by 17.0 to 19.0 % when a source of cholesterol was present and increased neurite branching by 4.03- to 9.54-fold (regardless of exogenous cholesterol). Neurite elongation was increased by treatment with lovastatin only in cholesterol-free culture conditions. Treatment with lovastatin decreased growth cone actin filament content by up to 24.3 %. In all cases, co-treatment with the prenylation precursor, geranylgeraniol (10 μM), reversed the effect of lovastatin. In a prior work, statin effects on outgrowth were linked to modulating the actin depolymerizing factor, cofilin. In our assays, treatment with lovastatin or geranylgeraniol decreased cofilin phosphorylation in whole cell lysates. However, lovastatin increased cofilin phosphorylation in cell bodies and decreased it in growth cones, indicating differential regulation in specific cell regions. Together, we interpret these data to suggest that protein geranylgeranylation likely regulates growth cone actin filament content and subsequent neurite outgrowth through mechanisms that also affect actin nucleation and polymerization.Keywords
This publication has 49 references indexed in Scilit:
- Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylationNeuroscience, 2012
- 3-Hydroxy-3-methylglutaryl–Coenzyme A Reductase Inhibitors in the Treatment of Central Nervous System DiseasesArchives of Neurology, 2010
- Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patientsNeurobiology of Disease, 2009
- Wnt5a Mediates Nerve Growth Factor-Dependent Axonal Branching and Growth in Developing Sympathetic NeuronsJournal of Neuroscience, 2009
- Mevastatin‐induced neurite outgrowth of neuroblastoma cells via activation of EGFRJournal of Neuroscience Research, 2009
- Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational ModificationJournal of Biological Chemistry, 2008
- WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cellsJournal of Cell Biology, 2008
- Functions of Rac GTPases during Neuronal DevelopmentDevelopmental Neuroscience, 2007
- RhoA‐kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factorJournal of Neurobiology, 2006
- The 3‐hydroxy‐3‐methylglutaryl co‐enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neuronsJournal of Neurochemistry, 2006